Digital Image Segmentation Analysis Enables High-Throughput Next-Generation Impactor Analysis

Abstract

Purpose:

Aerodynamic particle size distribution (APSD) determination is a key quality attribute for inhaled therapeutics. The next-generation impactor is the gold standard for APSD determination; however, it suffers from lengthy analysis times due to the need for high-performance liquid chromatography (HPLC)-based quantitation. In this work, a novel method employing image analysis is developed to derive APSD metrics from dry powder inhalers.

Major Findings:

Analysis of neat active pharmaceutical ingredient (API), API/lactose blends, and stressed blend samples is demonstrated. The method shows sufficient resolution to differentiate between different sizes of neat API and within lactose blends. In addition, the results obtained from image analysis are comparable to the HPLC derived results.

Conclusions:

This study establishes the feasibility of image analysis for faster APSD determination.

Keywords

APSD determination high-throughput NGI analysis NGI NGI sample preparation

Get full access to this article

View all access options for this article.

References

Mitchell

, Nagel

. Cascade impactors for the size characterization of aerosols from medical inhalers: Their uses and limitations. J Aerosol Med, 2003; 16(4):341–377; doi: 10.1089/089426803772455622

Leung

, Louca

, Gray

, et al. Use of the next generation pharmaceutical impactor for particle size distribution measurements of live viral aerosol vaccines. J Aerosol Med, 2005; 18(4):414–426; doi: 10.1089/jam.2005.18.414

, Ma

, Zhu

. The future of dry powder inhaled therapy: Promising or discouraging for systemic disorders? Int J Pharm, 2022; 614:121457; doi: 10.1016/j.ijpharm.2022.121457

Lee

, Adams

, Li

, et al. In vitro considerations to support bioequivalence of locally acting drugs in dry powder inhalers for lung diseases. Aaps J, 2009; 11(3):414–423; doi: 10.1208/s12248-009-9121-4

Islam

, Cleary

. Developing an efficient and reliable dry powder inhaler for pulmonary drug delivery—A review for multidisciplinary researchers. Med Eng Phys, 2012; 34(4):409–427; doi: 10.1016/j.medengphy.2011.12.025

Guo

, Gillespie

, Kauffman

, et al. Comparison of delivery characteristics from a combination metered-dose inhaler using the Andersen Cascade impactor and the next generation pharmaceutical impactor. J Pharm Sci, 2008; 97(8):3321–3334; doi: 10.1002/jps.21203

Marple

, Olson

, Miller

. The role of inertial particle collectors in evaluating pharmaceutical aerosol delivery systems. J Aerosol Med, 1998; 11(s1):S-139–S-153; doi: 10.1089/jam.1998.11.Suppl_1.S-139

European Pharmacopoeia . Section 2.9.18—Preparations for Inhalation: Aerodynamic Assessment of Fine Particles. 6th ed.. Council of Europe: Strasbourg. 2009; pp. 287–300.

Daniher

, Zhu

. Dry powder platform for pulmonary drug delivery. Particuology, 2008; 6(4):225–238; doi: 10.1016/j.partic.2008.04.004

10.

Marple

, Roberts

, Romay

, et al. Next generation pharmaceutical impactor (A New impactor for pharmaceutical inhaler testing). Part I: Design. J Aerosol Med, 2003; 16(3):283–299; doi: 10.1089/089426803769017659

11.

Kamiya

, Sakagami

, Hindle

, et al. Aerodynamic sizing of metered dose inhalers: An evaluation of the andersen and next generation pharmaceutical impactors and their USP methods. J Pharm Sci, 2004; 93(7):1828–1837; doi: 10.1002/jps.20091

12.

Taki

, Marriott

, Zeng

X-M

, et al. Aerodynamic deposition of combination dry powder inhaler formulations in vitro: A comparison of three impactors. Int J Pharm, 2010; 388(1–2):40–51; doi: 10.1016/j.ijpharm.2009.12.031

13.

United States Pharmacopeial Convention. Aerosols, Nasal Sprays, Metered-Dose Inhalers, and Dry Powder Inhalers <601>. United States Pharmacopeial Convention: Rockville, MD, USA; 2010. doi: 10.31003/USPNF_M99360_06_01

14.

United States Food and Drug Administration. FDA CDER Draft Guidelines for Metered Dose Inhaler (MDI) and Dry Powder Inhaler (DPI) Drug Products. Silver Spring, MD; 2018. Available from: https://www.fda.gov/media/70851/download

15.

Schindelin

, Arganda-Carreras

, Frise

, et al. Fiji: An open-source platform for biological-image analysis. Nat Methods, 2012; 9(7):676–682; doi: 10.1038/nmeth.2019

16.

Tinevez

J-Y

, Perry

, Schindelin

, et al. TrackMate: An open and extensible platform for single-particle tracking. Methods, 2017; 115:80–90; doi: 10.1016/j.ymeth.2016.09.016

17.

Ershov

, Phan

M-S

, Pylvänäinen

, et al. TrackMate 7: Integrating state-of-the-art segmentation algorithms into tracking pipelines. Nat Methods, 2022; 19(7):829–832; doi: 10.1038/s41592-022-01507-1

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.16 MB